However, a study by Kennedy et al. shows that CCR5 has a minor role in regulating M1 ATMs infiltration but increases influx of CD4+ T into hypertrophic adipose tissue [19], indicating that targeting CCR5 only may not be the best approach for treating obesity-induced adipose tissue inflammation. The gene discussed is CCR5; the disease is obesity disorder.